84 related articles for article (PubMed ID: 12459507)
1. The CB1 receptor antagonist SR141716 enhances stimulus-induced activation of the primary somatosensory cortex of the rat.
Patel S; Gerrits R; Muthian S; Greene AS; Hillard CJ
Neurosci Lett; 2002 Dec; 335(2):95-8. PubMed ID: 12459507
[TBL] [Abstract][Full Text] [Related]
2. Endocannabinoid modulation of hyperaemia evoked by physiologically relevant stimuli in the rat primary somatosensory cortex.
Ho WS; Patel S; Thompson JR; Roberts CJ; Stuhr KL; Hillard CJ
Br J Pharmacol; 2010 Jun; 160(3):736-46. PubMed ID: 20590576
[TBL] [Abstract][Full Text] [Related]
3. Blockade of cannabinoid receptors by SR141716 selectively increases Fos expression in rat mesocorticolimbic areas via reduced dopamine D2 function.
Alonso R; Voutsinos B; Fournier M; Labie C; Steinberg R; Souilhac J; Le Fur G; Soubrié P
Neuroscience; 1999; 91(2):607-20. PubMed ID: 10366018
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological characterisation of cannabinoid CB(1) receptors in the rat and mouse.
Lay L; Angus JA; Wright CE
Eur J Pharmacol; 2000 Mar; 391(1-2):151-61. PubMed ID: 10720647
[TBL] [Abstract][Full Text] [Related]
5. SR141716, a CB1 receptor antagonist, decreases the sensitivity to the reinforcing effects of electrical brain stimulation in rats.
Deroche-Gamonet V; Le Moal M; Piazza PV; Soubrié P
Psychopharmacology (Berl); 2001 Sep; 157(3):254-9. PubMed ID: 11605080
[TBL] [Abstract][Full Text] [Related]
6. The effect of cannabinoid receptor antagonism with SR141716A on antinociception induced by cocaine and the NMDA receptor antagonist, MK-801.
Forman LJ
Brain Res Bull; 2003 Jul; 61(2):153-8. PubMed ID: 12832001
[TBL] [Abstract][Full Text] [Related]
7. Cannabinoid inhibition of capsaicin-sensitive sensory neurotransmission in the rat mesenteric arterial bed.
Ralevic V; Kendall DA
Eur J Pharmacol; 2001 Apr; 418(1-2):117-25. PubMed ID: 11334873
[TBL] [Abstract][Full Text] [Related]
8. The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells.
Bensaid M; Gary-Bobo M; Esclangon A; Maffrand JP; Le Fur G; Oury-Donat F; Soubrié P
Mol Pharmacol; 2003 Apr; 63(4):908-14. PubMed ID: 12644592
[TBL] [Abstract][Full Text] [Related]
9. Cannabinoid CB(1) receptor blockade enhances the protective effect of melanocortins in hemorrhagic shock in the rat.
Cainazzo MM; Ferrazza G; Mioni C; Bazzani C; Bertolini A; Guarini S
Eur J Pharmacol; 2002 Apr; 441(1-2):91-7. PubMed ID: 12007925
[TBL] [Abstract][Full Text] [Related]
10. Enhanced levels of endogenous cannabinoids in the globus pallidus are associated with a reduction in movement in an animal model of Parkinson's disease.
Di Marzo V; Hill MP; Bisogno T; Crossman AR; Brotchie JM
FASEB J; 2000 Jul; 14(10):1432-8. PubMed ID: 10877836
[TBL] [Abstract][Full Text] [Related]
11. Blockade of effects of smoked marijuana by the CB1-selective cannabinoid receptor antagonist SR141716.
Huestis MA; Gorelick DA; Heishman SJ; Preston KL; Nelson RA; Moolchan ET; Frank RA
Arch Gen Psychiatry; 2001 Apr; 58(4):322-8. PubMed ID: 11296091
[TBL] [Abstract][Full Text] [Related]
12. CB1 receptor antagonism in the granular insular cortex or somatosensory area facilitates consolidation of object recognition memory.
O'Brien LD; Sticht MA; Mitchnick KA; Limebeer CL; Parker LA; Winters BD
Neurosci Lett; 2014 Aug; 578():192-6. PubMed ID: 25004406
[TBL] [Abstract][Full Text] [Related]
13. Activity of SR141716 on post-reinforcement pauses in operant responding for sucrose reward in rats.
Pério A; Barnouin MC; Poncelet M; Soubrié P
Behav Pharmacol; 2001 Dec; 12(8):641-5. PubMed ID: 11856902
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of improgan antinociception by the cannabinoid (CB)(1) antagonist N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716A): lack of obligatory role for endocannabinoids acting at CB(1) receptors.
Hough LB; Nalwalk JW; Stadel R; Timmerman H; Leurs R; Paria BC; Wang X; Dey SK
J Pharmacol Exp Ther; 2002 Oct; 303(1):314-22. PubMed ID: 12235266
[TBL] [Abstract][Full Text] [Related]
15. Temporally staggered forelimb stimulation modulates barrel cortex optical intrinsic signal responses to whisker stimulation.
Blood AJ; Pouratian N; Toga AW
J Neurophysiol; 2002 Jul; 88(1):422-37. PubMed ID: 12091565
[TBL] [Abstract][Full Text] [Related]
16. The hypnotic actions of oleamide are blocked by a cannabinoid receptor antagonist.
Mendelson WB; Basile AS
Neuroreport; 1999 Oct; 10(15):3237-9. PubMed ID: 10574567
[TBL] [Abstract][Full Text] [Related]
17. Not glutamate but endocannabinoids mediate retrograde suppression of cerebellar parallel fiber to Purkinje cell synaptic transmission in young adult rodents.
Tanimura A; Kawata S; Hashimoto K; Kano M
Neuropharmacology; 2009 Aug; 57(2):157-63. PubMed ID: 19447120
[TBL] [Abstract][Full Text] [Related]
18. Early tolerance to the hypophagic effect of the cannabinoid receptor antagonist SR141716 does not impede blockade of an orexigenic stimulus.
Rigamonti AE; Giordani C; Bonomo SM; Cella SG; Müller EE
Eur J Pharmacol; 2006 Aug; 542(1-3):116-20. PubMed ID: 16806163
[TBL] [Abstract][Full Text] [Related]
19. The CB1 receptor antagonist SR141716A selectively increases monoaminergic neurotransmission in the medial prefrontal cortex: implications for therapeutic actions.
Tzavara ET; Davis RJ; Perry KW; Li X; Salhoff C; Bymaster FP; Witkin JM; Nomikos GG
Br J Pharmacol; 2003 Feb; 138(4):544-53. PubMed ID: 12598408
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the reinforcing effects of the cannabinoid CB1 receptor antagonist, SR141716, in rhesus monkeys.
Beardsley PM; Dance ME; Balster RL; Munzar P
Eur J Pharmacol; 2002 Jan; 435(2-3):209-16. PubMed ID: 11821028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
